Pfizer (PFE) EBT (QoQ) (2009 - 2026)
Pfizer (PFE) EBT (QoQ) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 654.62 Bn | 633.86 Bn | 17.26 Bn |
| 2 | AbbVie | 471.49 Bn | 464.92 Bn | 12.70 Bn |
| 3 | Merck | 380.76 Bn | 373.62 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.50 Bn | 295.81 Bn | 11.24 Bn |
| 5 | Astrazeneca | 258.69 Bn | 253.79 Bn | 12.86 Bn |
| 6 | Amgen | 237.83 Bn | 223.84 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 183.09 Bn | 179.91 Bn | 6.22 Bn |
| 8 | Pfizer | 161.60 Bn | 149.90 Bn | 10.94 Bn |
| 9 | Gsk | 105.97 Bn | 101.81 Bn | 8.24 Bn |
| 10 | Sanofi | 55.33 Bn | 47.95 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 28, 2026 | -120.60% |
| Mar 29, 2026 | 293.06% |
| Dec 31, 2025 | -149.25% |
| Sep 28, 2025 | 9.53% |
| Jun 29, 2025 | 9.30% |
| Sep 29, 2024 | 7,899.03% |
| Jun 30, 2024 | -103.01% |
| Mar 31, 2024 | 182.85% |
| Jul 2, 2023 | -63.81% |
| Jul 3, 2022 | 26.49% |
| Oct 3, 2021 | 194.78% |
| Jul 4, 2021 | 22.08% |
| Sep 27, 2020 | 112.76% |
| Jun 28, 2020 | 6.47% |
| Mar 29, 2020 | 136.12% |
| Dec 31, 2019 | -173.36% |
| Sep 29, 2019 | 159.04% |
| Jun 30, 2019 | -4.21% |
| Mar 31, 2019 | 146.80% |
| Dec 31, 2018 | -321.14% |